IL132571A0 - Ergoline derivatives and ther use as somatostatin receptor antagonists - Google Patents
Ergoline derivatives and ther use as somatostatin receptor antagonistsInfo
- Publication number
- IL132571A0 IL132571A0 IL13257198A IL13257198A IL132571A0 IL 132571 A0 IL132571 A0 IL 132571A0 IL 13257198 A IL13257198 A IL 13257198A IL 13257198 A IL13257198 A IL 13257198A IL 132571 A0 IL132571 A0 IL 132571A0
- Authority
- IL
- Israel
- Prior art keywords
- receptor antagonists
- somatostatin receptor
- ergoline derivatives
- ther use
- ther
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9711043.1A GB9711043D0 (en) | 1997-05-29 | 1997-05-29 | Organic compounds |
| PCT/EP1998/003125 WO1998054183A2 (en) | 1997-05-29 | 1998-05-27 | Ergoline derivatives and their use as somatostatin receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL132571A0 true IL132571A0 (en) | 2001-03-19 |
Family
ID=10813201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13257198A IL132571A0 (en) | 1997-05-29 | 1998-05-27 | Ergoline derivatives and ther use as somatostatin receptor antagonists |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6221870B1 (xx) |
| EP (1) | EP0986558A2 (xx) |
| JP (1) | JP2001527580A (xx) |
| KR (1) | KR20010013103A (xx) |
| CN (1) | CN1259946A (xx) |
| AR (1) | AR012870A1 (xx) |
| AU (1) | AU727841B2 (xx) |
| BR (1) | BR9809491A (xx) |
| CA (1) | CA2288810A1 (xx) |
| CO (1) | CO4950561A1 (xx) |
| CZ (1) | CZ289466B6 (xx) |
| GB (1) | GB9711043D0 (xx) |
| HU (1) | HUP0002311A3 (xx) |
| ID (1) | ID22916A (xx) |
| IL (1) | IL132571A0 (xx) |
| NO (1) | NO995482L (xx) |
| NZ (1) | NZ500386A (xx) |
| PE (1) | PE74899A1 (xx) |
| PL (1) | PL336502A1 (xx) |
| RU (1) | RU2191776C2 (xx) |
| SK (1) | SK160899A3 (xx) |
| TR (1) | TR199902848T2 (xx) |
| WO (1) | WO1998054183A2 (xx) |
| ZA (1) | ZA984560B (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
| US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
| DE10341317B4 (de) * | 2003-09-03 | 2008-10-23 | Axxonis Pharma Ag | Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid |
| CA2449634C (en) * | 2001-06-08 | 2011-08-02 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Somatostatin-dopamine chimeric analogs |
| FI20031454A0 (fi) | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |
| KR101000923B1 (ko) * | 2004-01-08 | 2010-12-13 | 삼성전자주식회사 | 원격 제어기의 매크로 설정 장치 및 방법 |
| WO2006123020A1 (en) * | 2005-05-18 | 2006-11-23 | Juvantia Pharma Ltd Oy | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| JP2007067096A (ja) * | 2005-08-30 | 2007-03-15 | Fujitsu Ltd | 半導体装置 |
| IN2012DN04858A (xx) * | 2009-12-23 | 2015-09-25 | Map Pharmaceuticals Inc | |
| CN103827113A (zh) * | 2011-06-23 | 2014-05-28 | Map药物公司 | 新型氟麦角碱类似物 |
| AU2012355982A1 (en) | 2011-12-19 | 2014-07-10 | Map Pharmaceuticals, Inc. | Novel iso-ergoline derivatives |
| AU2012355983A1 (en) | 2011-12-21 | 2015-01-22 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| JP2016503402A (ja) | 2012-11-01 | 2016-02-04 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． | ソマトスタチン類似体及びそのダイマー |
| TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素－多巴胺嵌合體類似物 |
| JP6856532B2 (ja) | 2015-01-20 | 2021-04-07 | エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ | エルゴリン化合物およびその使用 |
| BR112017015510A2 (pt) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo |
| MX2019014272A (es) | 2017-06-01 | 2020-12-11 | Xoc Pharmaceuticals Inc | Compuestos policiclicos y usos de los mismos. |
| JP7099717B2 (ja) | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH475252A (de) * | 1966-02-08 | 1969-07-15 | Sandoz Ag | Verfahren zur Herstellung neuer Lysergsäure-Derivate |
| US3592816A (en) | 1966-02-08 | 1971-07-13 | Sandoz Ltd | N-substituted piperazides of lysergic acid |
| GB1188197A (en) | 1967-10-11 | 1970-04-15 | Sandoz Ltd | Lysergic Acid Derivatives |
| NL6818658A (xx) * | 1968-01-18 | 1969-07-22 | ||
| GB1580448A (en) * | 1976-12-06 | 1980-12-03 | Farmaceutici Italia | 8 -acetyl-6-methyl-ergoline i derivatives |
| GB8501078D0 (en) * | 1985-01-16 | 1985-02-20 | Erba Farmitalia | Piperazin-1-yl-ergo-line derivatives |
| TW357143B (en) | 1995-07-07 | 1999-05-01 | Novartis Ag | Benzo[g]quinoline derivatives |
-
1997
- 1997-05-29 GB GBGB9711043.1A patent/GB9711043D0/en active Pending
-
1998
- 1998-05-27 EP EP98932090A patent/EP0986558A2/en not_active Withdrawn
- 1998-05-27 CA CA002288810A patent/CA2288810A1/en not_active Abandoned
- 1998-05-27 PL PL98336502A patent/PL336502A1/xx unknown
- 1998-05-27 WO PCT/EP1998/003125 patent/WO1998054183A2/en not_active Application Discontinuation
- 1998-05-27 CN CN98805488A patent/CN1259946A/zh active Pending
- 1998-05-27 PE PE1998000425A patent/PE74899A1/es not_active Application Discontinuation
- 1998-05-27 CZ CZ19994245A patent/CZ289466B6/cs not_active IP Right Cessation
- 1998-05-27 ID IDW991445A patent/ID22916A/id unknown
- 1998-05-27 BR BR9809491-2A patent/BR9809491A/pt not_active IP Right Cessation
- 1998-05-27 IL IL13257198A patent/IL132571A0/xx unknown
- 1998-05-27 AU AU82108/98A patent/AU727841B2/en not_active Ceased
- 1998-05-27 US US09/424,377 patent/US6221870B1/en not_active Expired - Fee Related
- 1998-05-27 RU RU99127433/04A patent/RU2191776C2/ru active
- 1998-05-27 HU HU0002311A patent/HUP0002311A3/hu unknown
- 1998-05-27 NZ NZ500386A patent/NZ500386A/en unknown
- 1998-05-27 KR KR19997011082A patent/KR20010013103A/ko active IP Right Grant
- 1998-05-27 TR TR1999/02848T patent/TR199902848T2/xx unknown
- 1998-05-27 AR ARP980102461A patent/AR012870A1/es unknown
- 1998-05-27 SK SK1608-99A patent/SK160899A3/sk unknown
- 1998-05-27 JP JP50023799A patent/JP2001527580A/ja active Pending
- 1998-05-28 ZA ZA984560A patent/ZA984560B/xx unknown
- 1998-05-28 CO CO98030085A patent/CO4950561A1/es unknown
-
1999
- 1999-11-09 NO NO995482A patent/NO995482L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK160899A3 (en) | 2000-07-11 |
| ID22916A (id) | 1999-12-16 |
| KR20010013103A (ko) | 2001-02-26 |
| CZ424599A3 (cs) | 2000-03-15 |
| HUP0002311A2 (hu) | 2000-12-28 |
| AU727841B2 (en) | 2001-01-04 |
| WO1998054183A2 (en) | 1998-12-03 |
| CA2288810A1 (en) | 1998-12-03 |
| CZ289466B6 (cs) | 2002-01-16 |
| NZ500386A (en) | 2002-05-31 |
| JP2001527580A (ja) | 2001-12-25 |
| AR012870A1 (es) | 2000-11-22 |
| TR199902848T2 (xx) | 2000-02-21 |
| AU8210898A (en) | 1998-12-30 |
| HUP0002311A3 (en) | 2002-08-28 |
| ZA984560B (en) | 1998-11-30 |
| NO995482D0 (no) | 1999-11-09 |
| WO1998054183A3 (en) | 1999-03-04 |
| CO4950561A1 (es) | 2000-09-01 |
| NO995482L (no) | 1999-11-09 |
| US6221870B1 (en) | 2001-04-24 |
| PL336502A1 (en) | 2000-07-03 |
| EP0986558A2 (en) | 2000-03-22 |
| BR9809491A (pt) | 2000-10-17 |
| CN1259946A (zh) | 2000-07-12 |
| RU2191776C2 (ru) | 2002-10-27 |
| PE74899A1 (es) | 1999-09-14 |
| GB9711043D0 (en) | 1997-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL132571A0 (en) | Ergoline derivatives and ther use as somatostatin receptor antagonists | |
| SI1035115T1 (en) | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists | |
| HK1019149A1 (en) | Indole derivatives useful as endothelin receptor antagonists | |
| IL133870A0 (en) | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation | |
| HUP0002373A3 (en) | Glucagon antagonists/inverse agonists | |
| CY2576B1 (en) | Vitronectin receptor antagonists | |
| IL139835A (en) | Imidazolyl derivatives and their use as somatostatin receptor ligands | |
| HU9603525D0 (en) | Vironectin receptor antagonists | |
| AU2764797A (en) | Somatostatin agonists and antagonists | |
| EP0880511A4 (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| AU2020497A (en) | Receptor and transporter antagonists | |
| PL341114A1 (en) | Antagonists of thrombosin receptors | |
| HUP0203371A3 (en) | Adenosine receptor antagonists and methods of making and using the same | |
| EP0913389A4 (en) | CYCLOPROPYLGLYCINE DERIVATIVES AND AGONISTS OF THE L-GLUTAMATE RECEPTOR TYPE OF METABOLITE REGULATION | |
| PL330708A1 (en) | Derivatives of indolydine useful as antagonists of 5-ht-2c receptor | |
| GB9600344D0 (en) | Benzimidzolyl neuropeptide y receptor antagonists | |
| PL330796A1 (en) | Derivatives of indolin useful as antagonists of 5-ht-2c receptor | |
| AU3935897A (en) | B1-bradykinin receptor antagonists and use thereof | |
| NZ314277A (en) | Octopeptide somatostatin antagonist | |
| AUPP058597A0 (en) | Receptor agonists and antagonists | |
| SI1003504T1 (en) | Indole derivatives and their use as mcp-1 antagonists | |
| SI0912556T1 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
| GB9703015D0 (en) | Alpha v B3 antagonists | |
| HUP9903968A3 (en) | Non-peptide bombesin receptor antagonists and use thereof | |
| GB9603373D0 (en) | Integrin receptor antagonists |